Source: Eur Respir J, 55 (2) 1900806; 10.1183/13993003.00806-2019
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
Åsa Lina M. Jönsson, Elisabeth Bendstrup, Susie Mogensen, Elizabeth J. Kopras, Francis X. McCormack, Ilaria Campo, Francesca Mariani, Amparo Escribano-Montaner, Are M. Holm, Maria del Mar Martinez-Colls, Guillem Pintos-Morell, Camille Taillé, Bruno Crestani, Ole Hilberg, Jane Hvarregaard Christensen, Ulf Simonsen. Eight novel variants in the SLC34A2 gene in pulmonary alveolar microlithiasis. Eur Respir J, 55 (2) 1900806; 10.1183/13993003.00806-2019

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary alveolar proteinosis due to a novel mutation in CSF2RA Source: Annual Congress 2012 - Paediatric bronchology Year: 2012 New mutation associated to the pulmonary alveolar microlithiasis Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Different mutations in the SLC34A2 gene are showed in Chinese patients of pulmonary alveolar microlithiasis Source: Annual Congress 2009 - Genetics of lung diseases Year: 2009 Identification of a chromosome location linked to pulmonary alveolar microlithiasis (PAM) Source: Eur Respir J 2005; 26: Suppl. 49, 269s Year: 2005 Association of pulmonary alveolar proteinosis and fibrosis: patient with GATA2 deficiency Source: Eur Respir J 2016; 48: 1510-1514 Year: 2016 Familial interstitial lung disease and ABCA3 gene Gly964Asp mutation Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene Source: Eur Respir J 2004; 24: 30-39 Year: 2004 Pulmonary alveolar proteinosis due to heterozygous mutation in OAS1: Treatment of a novel disease with whole lung lavages and stem cell transplantation Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans Year: 2019 MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Combined pulmonary fibrosis and emphysema syndrome associated with ABCA3 mutations Source: Eur Respir J 2014; 43: 638-641 Year: 2013 Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis Source: Eur Respir J, 49 (5) 1700178; 10.1183/13993003.00178-2017 Year: 2017 Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis Source: Eur Respir J, 49 (5) 1700407; 10.1183/13993003.00407-2017 Year: 2017 Pulmonary alveolar microlithiasis (PAM) Source: Eur Respir J 2001; 18: Suppl. 33, 220s Year: 2001 Pulmonary alveolar microlithiasis Source: International Congress 2019 – Insights into paediatric bronchology Year: 2019 Pulmonary alveolar microlithiasis Source: Eur Respir Rev, 29 (158) 200024; 10.1183/16000617.0024-2020 Year: 2020 Pulmonary alveolar microlithiasis: two case reports and review of the literature Source: Eur Respir Rev 2012 21:249-256 Year: 2012 Stability of housekeeping genes in alveolar macrophages from COPD patients Source: Eur Respir J 2006; 27: 300-306 Year: 2006 Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Hereditary pulmonary alveolar proteinosis caused by recessive CSF2RB mutations Source: Eur Respir J 2011; 37: 201-204 Year: 2011 Pediatric interstitial lung disease caused by a novel ABCA3 mutation: ABCA3G964A Source: Annual Congress 2009 - Cell biology of lung disease Year: 2009